Alterations in myocardial metabolic substrate have been related to heart failure and dilated cardiomyopathy (Neubauer et al., 1997) and it is noteworthy that DCM patients show CD36 deficiency (Tanaka et al., 1997). This evidence concerns the gene CD36 and heart failure.